These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 33021537)
1. Survival With Continuous Outpatient Intravenous Inotrope Therapy in the Modern Era. Mody BP; Khan MH; Zaid S; Ahn C; Lloji A; Aronow WS; Gupta CA; Levine A; Gass AL; Cooper HA; Lanier GM Am J Ther; 2020 Oct; 28(6):e621-e630. PubMed ID: 33021537 [TBL] [Abstract][Full Text] [Related]
2. Palliative Inotropes in Advanced Heart Failure: Comparing Outcomes Between Milrinone and Dobutamine. Sami F; Acharya P; Noonan G; Maurides S; Al-Masry AA; Bajwa S; Parimi N; Boda I; Tran C; Goyal A; Mastoris I; Dalia T; Sauer A; Bakel AV; Shah Z J Card Fail; 2022 Dec; 28(12):1683-1691. PubMed ID: 36122816 [TBL] [Abstract][Full Text] [Related]
3. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure. Gorodeski EZ; Chu EC; Reese JR; Shishehbor MH; Hsich E; Starling RC Circ Heart Fail; 2009 Jul; 2(4):320-4. PubMed ID: 19808355 [TBL] [Abstract][Full Text] [Related]
4. Rehospitalization of Patients with Advanced Heart Failure Receiving Continuous, Palliative Dobutamine or Milrinone. Eaton RE; Kissling KT; Haas GJ; McLaughlin EM; Pickworth KK Am J Cardiol; 2022 Dec; 184():80-89. PubMed ID: 36167736 [TBL] [Abstract][Full Text] [Related]
5. Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock. Biswas S; Malik AH; Bandyopadhyay D; Gupta R; Goel A; Briasoulis A; Fonarow GC; Lanier GM; Naidu SS Curr Probl Cardiol; 2023 Aug; 48(8):101245. PubMed ID: 35545181 [TBL] [Abstract][Full Text] [Related]
6. Use of Outpatient Intravenous Calcitropes for Heart Failure in the United States. Gottlieb SS; Psotka MA; Desai N; Lindenfeld J; Russo P; Allen LA J Card Fail; 2021 Nov; 27(11):1276-1279. PubMed ID: 34265464 [TBL] [Abstract][Full Text] [Related]
7. Comparative Effectiveness and Safety Between Milrinone or Dobutamine as Initial Inotrope Therapy in Cardiogenic Shock. Lewis TC; Aberle C; Altshuler D; Piper GL; Papadopoulos J J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):130-138. PubMed ID: 30175599 [TBL] [Abstract][Full Text] [Related]
8. Effect of Inpatient Dobutamine versus Milrinone on Out-of-Hospital Mortality in Patients with Acute Decompensated Heart Failure. King JB; Shah RU; Sainski-Nguyen A; Biskupiak J; Munger MA; Bress AP Pharmacotherapy; 2017 Jun; 37(6):662-672. PubMed ID: 28475215 [TBL] [Abstract][Full Text] [Related]
9. Clinical Characteristics and Outcomes of Intravenous Inotropic Therapy in Advanced Heart Failure. Hashim T; Sanam K; Revilla-Martinez M; Morgan CJ; Tallaj JA; Pamboukian SV; Loyaga-Rendon RY; George JF; Acharya D Circ Heart Fail; 2015 Sep; 8(5):880-6. PubMed ID: 26179184 [TBL] [Abstract][Full Text] [Related]
10. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure. Arnold LM; Crouch MA; Carroll NV; Oinonen MJ Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484 [TBL] [Abstract][Full Text] [Related]
11. Continuous Cardiac Inotropes in Patients With End-Stage Heart Failure: An Evolving Experience. Malotte K; Saguros A; Groninger H J Pain Symptom Manage; 2018 Jan; 55(1):159-163. PubMed ID: 29030210 [TBL] [Abstract][Full Text] [Related]
12. Intraoperative milrinone versus dobutamine in cardiac surgery patients: a retrospective cohort study on mortality. Nielsen DV; Torp-Pedersen C; Skals RK; Gerds TA; Karaliunaite Z; Jakobsen CJ Crit Care; 2018 Feb; 22(1):51. PubMed ID: 29482650 [TBL] [Abstract][Full Text] [Related]
13. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide. Kurien S; Warfield KT; Wood CM; Miller WL Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223 [TBL] [Abstract][Full Text] [Related]
15. Symptomatic improvement in patients treated with intermittent infusion of inotropes: a double-blind placebo controled pilot study. López-Candales A; Vora T; Gibbons W; Carron C; Simmons P; Schwartz J J Med; 2002; 33(1-4):129-46. PubMed ID: 12939113 [TBL] [Abstract][Full Text] [Related]
16. Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial. Aranda JM; Schofield RS; Pauly DF; Cleeton TS; Walker TC; Monroe VS; Leach D; Lopez LM; Hill JA Am Heart J; 2003 Feb; 145(2):324-9. PubMed ID: 12595851 [TBL] [Abstract][Full Text] [Related]
17. Comparison between mixed venous oxygen saturation and thermodilution cardiac output in monitoring patients with severe heart failure treated with milrinone and dobutamine. Nuñez S; Maisel A Am Heart J; 1998 Mar; 135(3):383-8. PubMed ID: 9580093 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Positive Inotropic Agents in the Management of Acute Decompensated Heart Failure. Kelly J; Cheng J; Malloy R; Lupi K J Cardiovasc Pharmacol; 2020 May; 75(5):455-459. PubMed ID: 32091426 [TBL] [Abstract][Full Text] [Related]
19. Continuous Intravenous Inotropic Support for Advanced Heart Failure: Palliative Considerations. McPherson A; Nguyen C; Groninger H; Anderson KM; Henderson P; Rao A J Pain Palliat Care Pharmacother; 2022 Mar; 36(1):59-67. PubMed ID: 35319327 [TBL] [Abstract][Full Text] [Related]
20. The effect of dobutamine vs milrinone in sepsis: A big data, real-world study. Zhu Y; Yin H; Zhang R; Ye X; Wei J Int J Clin Pract; 2021 Nov; 75(11):e14689. PubMed ID: 34331721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]